Early Graft-Versus-Host Disease Prophylaxis to Prevent Cytokine Release Syndrome after Haploidentical Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
- 5 May 2026
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 32 (9) , 1074.e1-1074.e4
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II StudyTransplantation and Cellular Therapy, 2025
- Reduced Cytokine Release Syndrome and Improved Outcomes with Earlier Immunosuppressive Therapy in Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2024
- Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCTBlood, 2023
- Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideTransplantation and Cellular Therapy, 2022
- Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysisBone Marrow Transplantation, 2021